Navigation Links
Immucor Schedules Second Quarter Earnings Release and Conference Call
Date:12/29/2008

NORCROSS, Ga., Dec. 29 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it expects to release its fiscal second quarter earnings on Wednesday, January 7, 2009, after the close of regular trading hours, and then host a conference call on Thursday, January 8, 2009 at 8:30 AM (EST) to review the results. Investors are invited to participate in this conference call, with Dr. Gioacchino De Chirico, President and Chief Executive Officer, Richard A. Flynt, Chief Financial Officer, and Edward L. Gallup, consultant. The call will focus on the results for the second quarter and general business trends. The earnings release will be posted on Immucor's website, as well as any material financial information that may be discussed by Dr. De Chirico, Mr. Flynt, or Mr. Gallup during this call that is not contained in the earnings release. Both the earnings release and the additional financial information, if any, will be posted as soon as practicable after the call on the investor news section of Immucor's website. To access this information once posted, go to Immucor's website at www.immucor.com and click on "About Us - Press Releases."

To participate in the telephone conference call, dial 1-888-324-7567 and passcode BLUD. Replays of the conference call will be available for one week beginning at 12:00 noon on January 8th by calling 1-866-457-5510 and passcode 2468. Beginning January 15, 2009, audio of the conference call or a transcript of the audio will be available on the "About Us - Press Releases" page of the Immucor website.

For more information on Immucor, please visit our website at www.immucor.com.

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments.


'/>"/>
SOURCE Immucor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. FDA Accepts Immucors Response to Warning Letter
2. Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance
3. Immucor CEOs Italian Trial Moves Toward Second Phase
4. Immucor To Acquire BioArray Solutions Ltd.
5. Immucor Responding to FTC Inquiry
6. Immucor Settles SEC Investigation
7. Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call
8. Accuray Reschedules Announcement of Results for First Quarter of Fiscal 2009
9. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
10. Thoratec Schedules Third Quarter 2008 Conference Call, Webcast
11. WuXi PharmaTech Schedules Third Quarter 2008 Earnings Release on Wednesday, November 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , February 12, 2016 ... Efforts by Enabling Scientific Understanding of Complex Diseases ... Rare Diseases --> ... diagnostics in South Asia and a leading provider of ... contribute $10 million to the GenomeAsia 100K consortium ...
(Date:2/11/2016)... Germany and GERMANTOWN, ... QGEN ; Frankfurt Prime Standard: QIA) today announced ... RNA Panels for gene expression profiling, expanding QIAGEN,s portfolio ... The panels enable researchers to select from over 20,000 ... and discover interactions between genes, cellular phenotypes and disease ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics, ... sponsor of the 2016 BioProcess International Awards – Recognizing Excellence in the ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... than 150 years, continues today to pursue the highest level of accuracy and ... instruments: the AR9 Refractometer and the AR5 Refractometer. Accurate, reliable and tough ...
Breaking Biology Technology:
(Date:2/2/2016)... RESTON, Va. , Feb. 2, 2016 /PRNewswire/ ... contract award from the U.S. Army Research Office ... extend the range and sensitivity of the company,s ... DoD,s Past Accounting Mission and, more generally, defense-related ... its DNA phenotyping capabilities (predicting appearance and ancestry ...
(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
(Date:1/27/2016)... 2016  Rite Track, Inc. a leading semiconductor equipment ... Chester, Ohio announced today the acquisition of PLUS ... in Austin, Texas , will significantly ... modifications, installations and technical support offerings for TEL Track ... commented, "PLUS has provided world class service including refurbishment, ...
Breaking Biology News(10 mins):